Key Points
- Insider selling: CME Group insider Hilda Harris Piell sold 5,753 shares on May 18 at an average price of $304.63, generating about $1.75 million. After the sale, she still held 27,702 shares, trimming her position by 17.2%.
- Strong recent results: CME Group beat earnings expectations in its latest quarter, posting $3.36 EPS versus the $3.11 consensus and revenue of $1.88 billion versus $1.77 billion expected. Revenue rose 14.5% year over year.
- Dividend and analyst outlook: The company announced a quarterly dividend of $1.30 per share, implying a 1.7% annual yield. Analysts currently have a consensus rating of Moderate Buy with an average price target of $305.29.
CME Group Inc. (NASDAQ:CME - Get Free Report) insider Hilda Harris Piell sold 5,753 shares of the business's stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company's stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
CME Group Stock Down 0.9%
CME Group stock opened at $302.37 on Wednesday. The firm has a market cap of $109.57 billion, a price-to-earnings ratio of 25.80, a P/E/G ratio of 3.69 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $257.17 and a fifty-two week high of $329.16. The firm has a fifty day moving average price of $297.54 and a two-hundred day moving average price of $288.74.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts' consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The business's revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.80 EPS. As a group, analysts forecast that CME Group Inc. will post 12.26 earnings per share for the current year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group's payout ratio is currently 44.37%.
Analysts Set New Price Targets
A number of research analysts have weighed in on CME shares. Raymond James Financial boosted their target price on shares of CME Group from $310.00 to $320.00 and gave the stock an "outperform" rating in a research report on Monday, April 6th. Erste Group Bank raised shares of CME Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, March 5th. Morgan Stanley cut their price objective on shares of CME Group from $362.00 to $353.00 and set an "overweight" rating for the company in a research report on Thursday, April 23rd. The Goldman Sachs Group cut their price objective on shares of CME Group from $275.00 to $267.00 and set a "sell" rating for the company in a research report on Thursday, April 23rd. Finally, JPMorgan Chase & Co. upped their price objective on shares of CME Group from $266.00 to $271.00 and gave the company an "underweight" rating in a research report on Thursday, April 16th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $305.29.
Get Our Latest Analysis on CME
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the stock. Western Wealth Management LLC raised its position in shares of CME Group by 1,432.3% during the first quarter. Western Wealth Management LLC now owns 12,488 shares of the financial services provider's stock valued at $3,688,000 after buying an additional 11,673 shares during the last quarter. Ariadne Wealth Management LP acquired a new position in shares of CME Group during the first quarter valued at about $224,000. Bank of America Corp DE raised its position in shares of CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider's stock valued at $1,187,290,000 after buying an additional 1,130,587 shares during the last quarter. Edgestream Partners L.P. raised its position in shares of CME Group by 19.7% during the first quarter. Edgestream Partners L.P. now owns 15,433 shares of the financial services provider's stock valued at $4,558,000 after buying an additional 2,535 shares during the last quarter. Finally, Kentucky Retirement Systems raised its position in shares of CME Group by 15.3% during the first quarter. Kentucky Retirement Systems now owns 26,026 shares of the financial services provider's stock valued at $7,687,000 after buying an additional 3,447 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Key Stories Impacting CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME continues to benefit from solid fundamentals, including a recent earnings beat with stronger-than-expected revenue and EPS, plus a healthy dividend that supports shareholder returns.
- Positive Sentiment: New activity in CME-linked derivatives products, including growing interest in interest-rate and crypto-related futures, suggests the exchange remains well positioned to capture trading volume and product demand.
- Neutral Sentiment: Market commentary also noted CME as an alternative for investors concerned about correlation risk, which reflects the company’s role as a defensive financial market infrastructure name.
- Neutral Sentiment: The company adjourned voting on Class B proposals after a quorum shortfall at its 2026 annual meeting, a procedural issue that is unlikely to change the business outlook but may keep some attention on governance matters. Article Title
- Negative Sentiment: CEO Terrence Duffy sold 35,000 shares and insider Hilda Harris Piell sold 5,753 shares, which can weigh on sentiment because investors often view insider selling as a cautious signal. Article Title
About CME Group
(
Get Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
